Report cover image

Erythropoietin Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Oct 18, 2024
Length 117 Pages
SKU # PROD19315742

Description

Erythropoietin Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global erythropoietin drugs market is expected to grow at a CAGR of around 5.2% during 2025-2034. This report on global erythropoietin drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global erythropoietin drugs market by segmenting the market based on drug, product, application, end-user and region. Also, detailed profiles of companies operating in the erythropoietin drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Need for Surgical Interventions
• Increasing Awareness

Market Challenges

• Alternative Substitutes

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Drug

• Biologics
• Biosimilars

Market by Product

• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• Other Products

Market by Application

• Cancer
• Renal Diseases
• Neurology
• Other Applications

Market by End-User

• Hospitals
• Homecare
• Specialty Clinics
• Other End Users

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

117 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Erythropoietin Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Erythropoietin Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Erythropoietin Drugs Market by Drug
5.1. Introduction
5.2. Biologics
5.3. Biosimilars
6. Global Erythropoietin Drugs Market by Product
6.1. Introduction
6.2. Epoetin-alfa
6.3. Epoetin-beta
6.4. Darbepoetin-alfa
6.5. Other Products
7. Global Erythropoietin Drugs Market by Application
7.1. Introduction
7.2. Cancer
7.3. Renal Diseases
7.4. Neurology
7.5. Other Applications
8. Global Erythropoietin Drugs Market by End-User
8.1. Introduction
8.2. Hospitals
8.3. Homecare
8.4. Specialty Clinics
8.5. Other End Users
9. Global Erythropoietin Drugs Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. Amgen Inc.
13.2.2. Biocon Limited
13.2.3. Dr. Reddy’s Laboratories Ltd.
13.2.4. F. Hoffmann-La Roche AG
13.2.5. Intas Pharmaceuticals Ltd.
13.2.6. Johnson & Johnson
13.2.7. LG Chem Ltd.
13.2.8. Novartis AG
13.2.9. Pfizer Inc.
13.2.10. Sun Pharmaceutical Industries Ltd.
13.2.11. Teva Pharmaceutical Industries Ltd.
List of Figures
Figure 1: Global Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 2: Global Erythropoietin Drugs Market by Drug, 2024
Figure 3: Global Erythropoietin Drugs Market by Product, 2024
Figure 4: Global Erythropoietin Drugs Market by Application, 2024
Figure 5: Global Erythropoietin Drugs Market by End User, 2024
Figure 6: Global Erythropoietin Drugs Market by Region, 2024
Figure 7: Global Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 8: Global Erythropoietin Drugs Market by Drug (in %), 2024 & 2034
Figure 9: Global Biologics Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 10: Global Biologics Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 11: Global Biosimilars Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 12: Global Biosimilars Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 13: Global Erythropoietin Drugs Market by Product (in %), 2024 & 2034
Figure 14: Global Epoetin-alfa Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 15: Global Epoetin-alfa Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 16: Global Epoetin-beta Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 17: Global Epoetin-beta Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 18: Global Darbepoetin-alfa Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 19: Global Darbepoetin-alfa Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 20: Global Other Products Food Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 21: Global Other Products Food Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 22: Global Erythropoietin Drugs Market by Application (in %), 2024 & 2034
Figure 23: Global Cancer Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 24: Global Cancer Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 25: Global Renal Diseases Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 26: Global Renal Diseases Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 27: Global Neurology Erythropoietin Market (in US$ Million), 2020-2024
Figure 28: Global Neurology Erythropoietin Market (in US$ Million), 2025-2034
Figure 29: Global Other Applications Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 30: Global Other Applications Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 31: Global Erythropoietin Drugs Market by End-User (in %), 2024 & 2034
Figure 32: Global Hospitals Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 33: Global Hospitals Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 34: Global Homecare Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 35: Global Homecare Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 36: Global Specialty Clinics Erythropoietin Market (in US$ Million), 2020-2024
Figure 37: Global Specialty Clinics Erythropoietin Market (in US$ Million), 2025-2034
Figure 38: Global Other End Users Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 39: Global Other End Users Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 40: Global Erythropoietin Drugs Market by Region (in %), 2024 & 2034
Figure 41: Europe Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 42: Europe Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 43: Europe Erythropoietin Drugs Market by Country (in %), 2024 & 2034
Figure 44: Germany Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 45: United Kingdom Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 46: France Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 47: Italy Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 48: Spain Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 49: Russia Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 50: Netherlands Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 51: North America Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 52: North America Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 53: North America Erythropoietin Drugs Market by Country (in %), 2024 & 2034
Figure 54: United States Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 55: Canada Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 56: Asia Pacific Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 57: Asia Pacific Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 58: Asia Pacific Erythropoietin Drugs Market by Country (in %), 2024 & 2034
Figure 59: China Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 60: Japan Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 61: India Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 62: South Korea Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 63: Australia Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 64: Indonesia Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 65: Latin America Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 66: Latin America Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 67: Latin America Erythropoietin Drugs Market by Country (in %), 2024 & 2034
Figure 68: Mexico Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 69: Brazil Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 70: Argentina Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 71: Middle East & Africa Erythropoietin Drugs Market (in US$ Million), 2020-2024
Figure 72: Middle East & Africa Erythropoietin Drugs Market (in US$ Million), 2025-2034
Figure 73: Middle East & Africa Erythropoietin Drugs Market by Country (in %), 2024 & 2034
Figure 74: Saudi Arabia Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 75: Turkey Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 76: Iran Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 77: UAE Erythropoietin Drugs Market (in US$ Million), 2020-2034
Figure 78: Market Value Chain
List of Tables
Table 1: Global Erythropoietin Drugs Market Portraiture
Table 2: Global Erythropoietin Drugs Market by Drug (in US$ Million), 2024 & 2034
Table 3: Global Erythropoietin Drugs Market by Product (in US$ Million), 2024 & 2034
Table 4: Global Erythropoietin Drugs Market by Application (in US$ Million), 2024 & 2034
Table 5: Global Erythropoietin Drugs Market by End-User (in US$ Million), 2024 & 2034
Table 6: Global Erythropoietin Drugs Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Erythropoietin Drugs Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Erythropoietin Drugs Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Erythropoietin Drugs Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Erythropoietin Drugs Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Erythropoietin Drugs Market by Country (in US$ Million),
2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us